UX053
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UX053, covering 2024-04-16 to 2024-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III) [Phase 1, Phase 2]